ReviewMolecular biotechnology2026
Protein Nanocages as Versatile Vectors for Nucleic Acid Delivery: Main Systems and Their Loading Mechanisms.
Review in Molecular biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
The rapid advancement of nucleic acid-based technologies, such as mRNA vaccines and CRISPR-based gene editing, has transformed modern medicine. Yet, their full therapeutic potential remains constrained by the need for precise cargo loading and efficient delivery. This limitation has inspired the development of novel vector systems capable of both protecting nucleic acids and directing them to specific cellular targets. Protein nanocages have emerged as a highly versatile and programmable class of delivery vectors. Considerable research has focused on repurposing and engineering various platforms, including virus-like particles, encapsulins, and ferritins, to serve as robust nanocarriers. Using innovative strategies, researchers have developed sophisticated cargo-loading mechanisms that have evolved from simple electrostatic attraction to high-specificity, affinity-based systems that mimic viral packaging. At the same time, a deeper understanding of how nucleic acids interact with the nanocage interior is revealing some key structural factors that drive efficient packaging. In this review, we highlight the key advances in the design and application of protein nanocages for nucleic acid delivery. We analyze the primary systems and their distinct loading mechanisms, discuss current challenges, and explore future directions to help establish engineered nanomaterials as a new and powerful category of medical therapies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.